Xin Ba
- Geriatrics and Gerontology top 5%
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 6
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 11
-
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 3
-
- Cytokine Signaling Pathways and Interactions 6
-
- Autoimmune and Inflammatory Disorders Research 4
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- COVID-19 Clinical Research Studies 2
- Journals
- Frontiers in Immunology (6 papers)Journal of Ethnopharmacology (6 papers)Evidence-based Complementary and Alternative Medicine (4 papers)
- Partner nations
- China
In The Last Decade
Xin Ba
30 papers receiving 800 citations
Peers
Comparison fields: 5 of 99
- Geriatrics and Gerontology 53
- Pharmacology 113
- Rheumatology 178
- Complementary and alternative medicine 81
- Immunology 176
Countries citing papers authored by Xin Ba
This map shows the geographic impact of Xin Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Ba more than expected).
Fields of papers citing papers by Xin Ba
This network shows the impact of papers produced by Xin Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Ba. The network helps show where Xin Ba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 15 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 36 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 37 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 65 | |
| 14 | 2021 | 22 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 6 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 21 | |
| 19 | 2020 | 18 | |
| 20 | 2019 | 15 |
About Xin Ba
Xin Ba is a scholar working on Pharmacology, Rheumatology, Complementary and alternative medicine, Immunology and Hematology, having authored 30 papers that have together received 816 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Pharmacological Effects of Natural Compounds (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), Immune Cell Function and Interaction (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), T-cell and B-cell Immunology (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (53 citations), Pharmacology (113 citations), Rheumatology (178 citations), Complementary and alternative medicine (81 citations) and Immunology (176 citations). Xin Ba has collaborated with scholars based in China. Frequent co-authors include Pan Shen, Shenghao Tu, Kai Qin, Ying Huang, Yao Huang, Weiji Lin, Liang Han, Zhe Chen, Xuan Deng and Zhe Chen. Their work appears in journals such as Frontiers in Immunology, Journal of Ethnopharmacology, Evidence-based Complementary and Alternative Medicine, Frontiers in Pharmacology and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.